Managing pregnant patients with hematological tumors pose even more conflicts compared
to solid tumors. Unlike the majority of solid tumors, hematological malignancies are …

Cancer diagnosed during pregnancy constitutes a difficult clinical condition with a
devastating impact on the patient's somatic and psychosocial health and possibly on foetal …

Purpose Imatinib has potential teratogenicity in animals, but the effect of exposure to
imatinib during conception and pregnancy in humans is not known. Patients and Methods …

Leukemia in pregnancy remains a challenging therapeutic prospect. The prevalence is low
at∼ 1 in 10 000 pregnancies, and as a result data are limited to small retrospective series …

The prevalence of pregnancy associated leukemia is approximately 1 case out of 100,000
pregnancies. This rare occurrence precludes the conducting of large, prospective studies to …

The management of chronic myeloid leukemia (CML) diagnosed during pregnancy is a rare
and challenging situation. We report the treatment and outcome of 87 cases diagnosed in …

The NCCN Guidelines for Chronic Myeloid Leukemia (CML) provide recommendations for
the management of chronic-phase and advanced-phase CML in adult patients. The median …

Abstract Treatment of maternal chronic myeloid leukemia with imatinib mesylate is avoided
because of potential fetal effects. Two women with progression of disease during pregnancy …

Chronic Myelogenous Leukemia Clinical Practice Guidelines in Oncology NCCN Categories
of Evidence and Consensus Category 1: The recommendation is based on high-level …

With the improved survivals offered by the tyrosine kinase inhibitors has come the necessity
to address issues relating to quality of life and one such area is that of fertility and parenting …